All Business articles
View all stories with this category.
-
BusinessUS trade regulator sues to block Amgen–Horizon merger
Federal Trade Commission has concerns that union will allow Amgen to stifle potential competition for Horizon’s drugs
-
Business
The diabetes drugs aiming to aid weight loss
Can peptide hormone mimics avoid the side effect pitfalls of previous weight loss treatments?
-
Business
US supreme court confirms Amgen’s cholesterol antibody patents invalid
Decision could mean patent descriptions need to be even more detailed, and hence expensive
-
Opinion
Regulators must follow their heads, not their hearts
The 2019 US approval of antibiotic Recarbrio seems not to have met the normally expected standards
-
Business
Deadly explosion and fire at US pharmaceutical plant
One worker killed and four hospitalised at Seqens in Newburyport
-
Business
11 dead after toxic gas leak in India
Victims were instantly overwhelmed by gas, which left high concentrations of hydrogen sulfide in air
-
Business
UN asked to investigate ‘human rights violations’ by Chemours
Local campaigners claim PFAS emissions from US plant violate various rights, including to clean water and a sustainable environment
-
Business
Five dead after explosion at plant in China
Blast in hydrogen peroxide unit of Sinochem plant in Liaocheng
-
Business
DuPont and a senior employee plead guilty to criminal negligence
$16 million in fines and probation related to fatal methyl mercaptan leak at La Porte, US
-
Opinion
Battery materials going up in smoke
We cannot afford to simply throw away, rather than recycle, these valuable resources
-
Business
Making oil and water mix by encapsulation
Italian start-up Sphera Encapsulation can protect lipophilic food ingredients in aqueous environments
-
Business
Battery recyclers race to increase capacity and efficiency
As battery demand grows, recycling needs to capture more of the valuable resources in each cell
-
Opinion
Will a court overturn abortion drug’s approval?
Tangle between regulation and politics makes uncomfortable viewing from industry
-
Business
Merck & Co to buy immunology specialist Prometheus
$10.8 billion cash deal give Merck rights to late-stage candidate for two inflammatory bowel conditions
-
Business
Ghana and Nigeria approve Oxford malaria vaccine
Approval comes before final-stage clinical trials have been completed
-
Business
New Jersey sues Dow Chemical and others over 1,4-dioxane pollution
US State wants companies to be held accountable for cleaning up widespread contamination
-
Opinion
Meeting the tigers of the lab
Practical teaching strikes a balance between removing hazards and learning to respect them
-
Opinion
Holding the keys to a powerful future
Competition to build battery supply chains means supercharging support to attract investment
-
Business
Pfizer to buy cancer biotech Seagen for $43 billion
Antibody-drug conjugate specialist will fill Pfizer’s cancer pipeline
-
Business
Fragrance firms face coordinated cartel probe
Givaudan, Firmenich, Symrise and IFF raided by competition authorities
